Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY

v3.24.1.u1
STOCKHOLDERS' EQUITY
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
A summary of changes in stockholders’ equity is presented below (in thousands): 
  Three Months Ended March 31, 2024
  Number of
Shares
Common
Stock
Additional
Paid-In
Capital
Retained
Earnings
Total
Balance at December 31, 2023 36,425  $ 364  $ 290,955  $ 4,320,581  $ 4,611,900 
Net earnings —  —  —  186,016  186,016 
Stock-based compensation expense —  —  6,114  —  6,114 
Issuance of stock 256  (3) —  — 
Dividends declared —  —  —  (27,239) (27,239)
Repurchase of shares (362) (4) (56,214) —  (56,218)
Balance at March 31, 2024 36,319  $ 363  $ 240,852  $ 4,479,358  $ 4,720,573 

  Three Months Ended March 31, 2023
  Number of
Shares
Common
Stock
Additional
Paid-In
Capital
Retained
Earnings
Total
Balance at December 31, 2022 36,571  $ 366  $ 327,878  $ 3,621,367  $ 3,949,611 
Net earnings —  —  —  131,301  131,301 
Stock-based compensation expense —  —  6,225  —  6,225 
Issuance of stock 287  (3) —  — 
Dividends declared —  —  —  (9,927) (9,927)
Repurchase of shares (93) (1) (9,999) —  (10,000)
Balance at March 31, 2023 36,765  $ 368  $ 324,101  $ 3,742,741  $ 4,067,210 
During the three months ended March 31, 2024 and 2023, our Board of Directors approved, and we paid, a quarterly cash dividend on common stock of $0.75 and $0.27 per share, respectively. During the three months ended March 31, 2024 and 2023, we reflected the applicable excise tax on share repurchases in Additional paid-in capital as part of the cost basis of the stock repurchased and recorded a corresponding liability in Accrued liabilities on the accompanying unaudited consolidated balance sheets.